These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30472913)

  • 21. Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models.
    Juretić M; Cetina-Čižmek B; Filipović-Grčić J; Hafner A; Lovrić J; Pepić I
    Eur J Pharm Sci; 2018 Jul; 120():133-141. PubMed ID: 29702232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydrocortisone loaded poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for topical ophthalmic administration: Preparation, characterization and evaluation of ophthalmic toxicity.
    Álvarez-Álvarez L; Barral L; Bouza R; Farrag Y; Otero-Espinar F; Feijóo-Bandín S; Lago F
    Int J Pharm; 2019 Sep; 568():118519. PubMed ID: 31310791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of ocular irritancy of prototype shampoo formulations by the isolated rabbit eye (IRE) test and bovine corneal opacity and permeability (BCOP) assay.
    Cooper KJ; Earl LK; Harbell J; Raabe H
    Toxicol In Vitro; 2001 Apr; 15(2):95-103. PubMed ID: 11287169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eye irritation testing of nanomaterials using the EpiOcular™ eye irritation test and the bovine corneal opacity and permeability assay.
    Kolle SN; Sauer UG; Moreno MC; Teubner W; Wohlleben W; Landsiedel R
    Part Fibre Toxicol; 2016 Apr; 13():18. PubMed ID: 27083156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicity evaluation of the photoprotective compound LQFM048: Eye irritation, skin toxicity and genotoxic endpoints.
    de Ávila RI; de Sousa Vieira M; Gaeti MP; Moreira LC; de Brito Rodrigues L; de Oliveira GA; Batista AC; Vinhal DC; Menegatti R; Valadares MC
    Toxicology; 2017 Feb; 376():83-93. PubMed ID: 27129947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells.
    Nakano T; Inoue R; Kimura T; Suzumura H; Tanino T; Yamazaki Y; Yoshikawa K; Tatemichi M
    Adv Ther; 2016 Aug; 33(8):1452-9. PubMed ID: 27384190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity.
    Yang Q; Liu S; Gu Y; Tang X; Wang T; Wu J; Liu J
    Int J Nanomedicine; 2019; 14():3955-3966. PubMed ID: 31239665
    [No Abstract]   [Full Text] [Related]  

  • 28. Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation.
    Lusthaus JA; Goldberg I
    Expert Opin Drug Saf; 2017 Sep; 16(9):1071-1078. PubMed ID: 28656780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.
    Holló G; Bozkurt B; Irkec M
    Expert Opin Pharmacother; 2009 Aug; 10(12):2015-24. PubMed ID: 19618994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brinzolamide : a review of its use in the management of primary open-angle glaucoma and ocular hypertension.
    Cvetkovic RS; Perry CM
    Drugs Aging; 2003; 20(12):919-47. PubMed ID: 14565787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for the evaluation of the eye irritation potential of different types of surfactants and silicones used in cosmetic products.
    Sá LL; Rodrigues RV; Alves VM; Gaspar LR
    Toxicol In Vitro; 2022 Jun; 81():105351. PubMed ID: 35331854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension.
    Jansook P; Stefánsson E; Thorsteinsdóttir M; Sigurdsson BB; Kristjánsdóttir SS; Bas JF; Sigurdsson HH; Loftsson T
    Eur J Pharm Biopharm; 2010 Oct; 76(2):208-14. PubMed ID: 20637867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of in vitro eye irritation potential by bovine corneal opacity and permeability (BCOP) assay to erythema scores in human eye sting test of surfactant-based formulations.
    Cater KC; Harbell JW
    Cutan Ocul Toxicol; 2008; 27(2):77-85. PubMed ID: 18568892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of eye irritation potential of liquid and granular laundry detergent formulas using the bovine corneal opacity and permeability (BCOP) assay.
    Cater KC; Harbell JW
    Cutan Ocul Toxicol; 2013 Sep; 32(3):210-21. PubMed ID: 23360218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eye irritation potential: palm-based methyl ester sulphonates.
    Yusof NZ; Azizul Hasan ZA; Abd Maurad Z; Idris Z
    Cutan Ocul Toxicol; 2018 Jun; 37(2):103-111. PubMed ID: 28693384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
    Katz G; Dubiner H; Samples J; Vold S; Sall K
    JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group.
    March WF; Ochsner KI
    Am J Ophthalmol; 2000 Feb; 129(2):136-43. PubMed ID: 10682964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of novel amisulpride-loaded liquid self-nanoemulsifying drug delivery systems via dual tackling of its solubility and intestinal permeability.
    Gamal W; Fahmy RH; Mohamed MI
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1530-1538. PubMed ID: 28447878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determination.
    Kalam MA; Alshamsan A; Aljuffali IA; Mishra AK; Sultana Y
    Drug Deliv; 2016; 23(3):896-907. PubMed ID: 24865289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular viability and death biomarkers enables the evaluation of ocular irritation using the bovine corneal opacity and permeability assay.
    Xie Z; Ye K; Chen SH; Liu L; He LC; Sang J; Meng H; Kuang R
    Toxicol Lett; 2021 Apr; 340():52-57. PubMed ID: 33421553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.